###### Strengths and limitations of this study

-   Extensive literature search of Medline and Embase with independent screening of all abstracts and eligible full-text publications by two investigators.

-   Extensive data extraction on risk factors for mortality within each study population.

-   Few studies were prospective and focused on measurement of post-discharge mortality as a primary outcome.

-   Heterogeneity in populations, duration of follow-up and high proportion of loss to follow-up may limit the external validity and underestimate outcome rates.

-   No optimal method to assess the risk of bias in included studies.

Introduction {#s1}
============

The third of 17 United Nations sustainable development goals (SDGs) emphasises preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce under-5 mortality to at least as low as 25 deaths per 1000 live births by the year 2030.[@R1] Although significant progress was made during the Millennium Development Goal era (1990--2015), preventable childhood deaths remain high in Southern Asia and sub-Saharan Africa.[@R2] These deaths result largely from infectious diseases (including malaria, pneumonia, diarrhoea, etc), which lead to sepsis.[@R3] Children are particularly vulnerable in the months following hospital discharge, with a growing body of research demonstrating that postdischarge deaths occur in similar numbers as during hospital admission. Despite the staggering burden of postdischarge mortality, this issue has been largely neglected when examining paediatric mortality from infectious disease. The 2017 United Nations World Health Assembly (WHA) resolution calling for improvement in prevention, diagnosis and management of sepsis is timely as it emphasises the need for improved follow-up care, particularly for developing countries, within their recommended actions for reducing the burden of sepsis globally.[@R4] Member states are urged to emphasise the impact of sepsis on public health, of which postdischarge mortality is a crucial aspect.[@R2] Thus, as the international community works towards achieving the WHA resolution and the third SDG, addressing the burden of paediatric postdischarge mortality is of utmost importance.

A systematic literature review conducted in 2012 examined the burden of paediatric postdischarge mortality in resource-poor countries.[@R5] This systematic review found that the rate of paediatric postdischarge death is often as high as in-hospital mortality rates, with two-thirds of these deaths occurring outside the health system, usually at home. Common risk factors for postdischarge mortality included young age, malnutrition, HIV, pneumonia and recent prior admissions.

Despite the high burden of postdischarge death, this issue continues to receive insufficient recognition at either national or international levels. The lack of research and data highlighting the burden of postdischarge mortality relegates care following discharge as a low priority to policy makers. Additional studies published since the last systematic review contribute to the growing evidence base that can galvanise both researchers and policy makers to action.

The purpose of this systematic review, therefore, is to update the literature addressing the critical nature of paediatric postdischarge mortality in resource-poor settings, propelling research and interventions towards the goal of reduced child mortality.

Methods {#s2}
=======

Objective and study eligibility criteria {#s2a}
----------------------------------------

The primary objective was to determine the risk factors and rates of mortality in children following discharge from hospitals in developing countries. [Table 1](#T1){ref-type="table"} outlines the study inclusion eligibility, determined through the Population, Interventions, Comparisons, Outcomes and Study Design format.

###### 

Population, Interventions, Comparisons, Outcomes and Study Design

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Population                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Paediatric patients discharged from hospitals in developing countries, as defined as those countries currently (2016) classified by the United Nations Development Programme as having a low Human Development Index plus those countries included previously (2011) as having a low Human Development Index.[@R6]

  Exclusion criteria:No paediatric data or paediatric data not differentiated from adult populations.No postdischarge information or patients not discharged from a hospital setting.Discharge was following a non-admission (eg, following birth).Studies representing a specific non-infectious disease population where postdischarge care and outcomes would likely be different than that following acute (primarily infectious) illness including:Surgical population;Specific congenital disease (cardiac, renal, etc);Cancer;Specific non-infectious admission including trauma, kidney disease, cardiac disease, ophthalmic disease, sickle cell disease, liver disease, epilepsy, burns, poisoning, asthma, etc.Study was unpublished, published only in abstract form or in a language other than English, or provided no original data.   

  Interventions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Studies may or may not include an interventional arm (ie, both arms of an RCT will be included).

  Comparisons                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         NA

  Outcomes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Primary outcome:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Postdischarge mortality assessed \>7 days following discharge.Secondary outcomes:In-hospital mortality;Risk factors for postdischarge mortality.

  Study design                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Eligible study designs include the following:Randomised controlled trials (RCTs);Prospective or retrospective cohort studies;Studies using surveillance data;Study designs which include a population discharged and then followed up (including case-control, mixed-methods).
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NA, not applicable.

Patient and public involvement {#s2b}
------------------------------

Patients and the public were not involved in the design or conduct of this study.

Search strategy {#s2c}
---------------

Articles published and indexed between 1 January 2012 and 18 July 2017 were identified using the MEDLINE and EMBASE databases within the OVID platform. The detailed search strategy for each database is outlined in online supplementary [appendix 1](#SP1){ref-type="supplementary-material"}. Studies conducted prior to 2012 were identified from a prior publication, using a similar search strategy.[@R5] Articles were included if the study was conducted in a developing country (defined as countries currently (2016) classified by the United Nations Development Programme as having a low Human Development Index plus those countries included previously (2011) as having a low Human Development Index[@R6]), included children admitted to hospital for medical reasons, and included follow-up to capture vital status during the postdischarge period.[@R5] Furthermore, references of all included articles were reviewed to identify other potentially eligible studies not captured in the systematic search.
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Study selection and data extraction {#s2d}
-----------------------------------

Two investigators (BN, LE) independently screened articles during two rounds of review. The first round consisted of reviewing all abstracts for the presence of specific exclusion criteria. The second round of review consisted of a detailed review of remaining articles in full-text format. In both rounds, any discrepancies were resolved through discussion and consensus. A third investigator (MOW) provided arbitration for any discrepancies not resolved through consensus.

For eligible studies, the characteristics extracted included author, title and year of publication, year of study, country, study design, facility, population (diarrhoea, malaria, all admissions, etc), time of enrolment (admission or discharge), number of subjects, age, sex and study eligibility criteria. Outcomes extracted included total number of subjects who died both in-hospital and following discharge, timing and location of postdischarge deaths, follow-up method and losses to follow-up, number of postdischarge rehospitalisations and health seeking, timing of rehospitalisations and health seeking and risk factors for postdischarge mortality. When extracting data on risk factors, the results of multivariate analysis were preferentially extracted over univariate analyses.

Risk of bias {#s2e}
------------

A formal risk of bias assessment, such as the Newcastle Ottawa Quality Assessment Scale for Cohort Studies, was not conducted since the primary outcome of the rate of postdischarge mortality was not exposure related among included studies. Primary factors leading to potential bias include the per cent follow-up as well as whether inclusion criteria were correctly applied to enrolled subjects, leading to a representative sample of the population. While the former was included in the outcome characteristics, the latter was not defined in any study. Thus, proportion of children successfully followed remains the primary indicator of risk of bias.

Data analysis and outcomes {#s2f}
--------------------------

Microsoft Excel (Redmond, Washington, USA) was used to compile extracted data. Due to varying populations, risk factors, definitions and types of results (eg, OR, HR), a formal meta-analysis was not deemed possible. Therefore, the analysis was descriptive in nature. The primary outcome was the proportion of discharged subjects who died during the postdischarge period. Secondary outcomes included the proportion of total deaths (in-hospital and postdischarge), which occurred following discharge, as well as risk factors associated with postdischarge mortality. Given that several distinct populations were evaluated, results were reported according to the underlying study population. Studies were grouped according to five underlying populations: (1) all admissions including those for infectious diseases, (2) malnutrition, (3) respiratory infection, (4) diarrhoeal diseases and (5) malaria/anaemia.

Results {#s3}
=======

Summary of included articles {#s3a}
----------------------------

A total of 1238 articles were identified through the systematic searches, with two additional articles identified independently. Of these, 1174 were excluded at the abstract stage and a further 55 were excluded during the full-text screening stage, resulting in 11 eligible studies ([figure 1](#F1){ref-type="fig"}, online supplementary [appendix 2](#SP1){ref-type="supplementary-material"}). These 11 studies were added to the 13 studies identified prior to 2012 through a similar systematic search,[@R5] resulting in a total of 24 included studies ([table 2](#T2){ref-type="table"}). Studies were grouped according to underlying population. Three studies examined either all admissions or all infectious admissions, five examined malnutrition, seven respiratory infection, three diarrhoeal diseases and six included children with malaria and/or anaemia. Seven randomised controlled trials, 12 prospective cohorts, 2 retrospective cohorts and 3 case-control studies were included. Two studies examined those admitted to a health centre, whereas the remaining 22 were conducted at various types and levels of hospitals. All studies were performed in a single country, and Bangladesh was the only non-African country in which included studies were conducted.
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###### 

Study characteristics

  Author ID                                                       Years of study                  Country                                    Design                      Facility type                Population                                                                Number of subjects   Age range    Age estimate and dispersion (months): mean (SD) or median (IQR)   Female proportion (%)
  --------------------------------------------------------------- ------------------------------- ------------------------------------------ --------------------------- ---------------------------- ------------------------------------------------------------------------- -------------------- ------------ ----------------------------------------------------------------- -----------------------
  All admissions/unspecified infectious admissions                                                                                                                                                                                                                                                                                                                                  
   Veirum *et al* [@R8]                                           January 1991--December 1996     Guinea-Bissau                              Prospective cohort          National Referral Hospital   All admissions                                                            3373                 \<6 y                                                                          
   Moisi *et al* [@R9]                                            January 2004--December 2008     Kenya                                      Retrospective cohort        District Hospital            All admissions                                                            10 277               \<15 y                                                                         
   Wiens *et al* [@R10]                                           March 2012--December 2013       Uganda                                     Prospective cohort          Regional Referral Hospital   Proven or suspected infection                                             1307                 6 m-5 y      18.10 (10.8--34.6)                                                45.1
  Malnutrition                                                                                                                                                                                                                                                                                                                                                                      
   Hennart *et al* [@R14]                                         1970                            Democratic Republic of the Congo (Zaire)   Prospective cohort          Hospital                     Severe protein-energy malnutrition                                        171                  0--6+ y      Mean=46                                                           
   Kerac *et al* [@R12]                                           July 2006--March 2007           Malawi                                     Prospective cohort          National Referral Hospital   Malnutrition                                                              1024                 5--168 m     21.5 (15.0--32.0)                                                 47
   Chisti *et al* [@R13]                                          April 2011--June 2012           Bangladesh                                 Prospective cohort          Hospital                     Severe malnutrition and radiological pneumonia                            405                  0--59 m      10 (5--18)                                                        44.2
   Berkley *et al* [@R15]                                         November 2009--March 2013       Kenya                                      RCT                         Hospital                     Severe acute malnutrition---cotrimoxazole                                 887                  2--59 m      11.2 (7.2--16.7)                                                  50%
  Severe acute malnutrition---placebo                             891                             10.8 (6.9--16.7)                           48%                                                                                                                                                                                                                                    
   Grenov *et al* [@R32]                                          March 2014--October 2015        Uganda                                     RCT                         National Referral Hospital   Severe acute malnutrition---probiotics                                    200                  6--59 m      17.5 (8.5)                                                        42.5
  Severe acute malnutrition---placebo                             200                             16.5 (8.4)                                 42.5                                                                                                                                                                                                                                   
  Respiratory Infection                                                                                                                                                                                                                                                                                                                                                             
   West *et al* [@R33]                                            May 1992--November 1994         The Gambia                                 Case-control                Hospital                     Acute lower respiratory tract infection                                   118                  \<5 y        Mean=9.7                                                          43.2
   Villamor *et al* [@R17]                                        1993--1997                      Tanzania                                   Prospective cohort          Hospital                     Pneumonia                                                                 687                  6--60 m      17.6 (12.1)                                                       45.8
   Ashraf *et al* [@R34]                                          September 2006--November 2008   Bangladesh                                 Prospective cohort          Hospital                     Severe pneumonia                                                          180                  2--59 m      7.3 (6.8)                                                         34.4
   Reddy *et al* [@R35]                                           November 2008--July 2009        Tanzania                                   RCT                         Regional Referral Hospital   Tuberculosis---standard diagnostics                                       10                   \<6 y        21 (5--47)                                                        70
  Tuberculosis---intensified diagnostics                          13                              10.5 (6.0--18.0)                           38.5                                                                                                                                                                                                                                   
   Chhibber *et al* [@R16]                                        May 2008--May 2012              The Gambia                                 Prospective cohort          Health Centre                Pneumonia, sepsis or meningitis                                           3952                 2--59 m                                                                        
   Ngari *et al* [@R18]                                           January 2007--December 2012     Kenya                                      Prospective cohort          District Hospital            Severe pneumonia                                                          2461                 1--59 m      9.3 (3.9--20.4)                                                   43.2
  No pneumonia                                                    5270                            19.5 (11.0--28.5)                          43.6                                                                                                                                                                                                                                   
   Newberry *et al* [@R36]                                        April 2012--August 2014         Malawi                                     RCT                         Hospital                     Pneumocystis jirovecii pneumonia (PJP)---intervention (corticosteroids)   36                   2--6 m       3.1 (2.7--3.9)                                                    66.7
  PJP---placebo                                                   42                              3.4 (2.9--4.4)                             50                                                                                                                                                                                                                                     
  Diarrhoea                                                                                                                                                                                                                                                                                                                                                                         
   Roy *et al* [@R19]                                             1979--1980                      Bangladesh                                 Prospective cohort          Health Centre                Diarrhoea                                                                 551                  3--36 m                                                                        
   Stanton *et al* [@R37]                                         October 1983--December 1983     Bangladesh                                 Retrospective cohort        Hospital                     Diarrhoea                                                                 112                  24--72 m                                                                       27
   Islam *et al* [@R20]                                           November 1991--December 1992    Bangladesh                                 Prospective cohort          Hospital                     Diarrhoea                                                                 427                  1--23 m                                                                        39.1
  Anaemia/Malaria                                                                                                                                                                                                                                                                                                                                                                   
   Zucker *et al* [@R24]                                          March 1991--September 1991      Kenya                                      Case-control                District Hospital            Anaemia (case)                                                            293                  \<60 m       9.8 (8.6)                                                         50
  No anaemia (control)                                            291                             13.5 (11.3)                                50                                                                                                                                                                                                                                     
   Biai *et al* [@R21]                                            December 2004--January 2006     Guinea-Bissau                              RCT                         National Referral Hospital   Malaria---intervention                                                    460                  3--60 m      24 (13--36)                                                       45.4
  Malaria---no intervention                                       491                             24 (14--39)                                43                                                                                                                                                                                                                                     
   Phiri *et al* [@R25]                                           July 2002--July 2004            Malawi                                     Longitudinal case-control   Hospital                     Severe anaemia                                                            377                  6--60 m      20.4 (12.8)                                                       53.6
  No anaemia                                                      377                             22.5 (12.1)                                47.7                                                                                                                                                                                                                                   
   Phiri *et al* [@R23]                                           June 2006-- August 2009         Malawi                                     RCT                         Hospital                     Severe malarial anaemia                                                   1414                 4--59 m      23.9 (13.4)                                                       51.6
   Olupot-Olupot *et al* [@R26]                                   2014                            Uganda                                     RCT                         Hospital                     Severe anaemia---higher blood transfusion volume (30 mL/kg)               78                   60 d--12 y   31 (11--48)                                                       51
  Severe anaemia---standard blood transfusion volume (20 mL/kg)   82                              36 (19--54)                                50                                                                                                                                                                                                                                     
   Opoka *et al* [@R22]                                           November 2008--October 2013     Uganda                                     Prospective cohort          National Referral Hospital   Cerebral malaria                                                          269                  18 m--12 y   3.9 (2.7--6.0)                                                    35.2
  Severe malarial anaemia                                         233                             2.8 (2.1--3.9)                             39.9                                                                                                                                                                                                                                   

d, day; m, month; RCT, randomised controlled trial; y, year.

All admissions, including unspecified infectious admissions {#s3b}
-----------------------------------------------------------

The three studies within this population were conducted between 1991 and 2013 in Guinea-Bissau, Kenya and Uganda, and enrolled between 1307 and 10 277 subjects ([table 2](#T2){ref-type="table"}).[@R8] Follow-up periods ranged from 6 months to 1 year, with postdischarge mortality ranging from 4.9% to 8% ([table 3](#T3){ref-type="table"}). Two studies reported postdischarge readmission, measured rates between 16.5% and 17.7%.[@R9] Inpatient mortality was recorded by two studies, finding rates of 4.9% and 15%.[@R8] These same studies recorded that most postdischarge deaths (67% and 77%) occurred outside of the hospital setting. The majority of postdischarge deaths occurred relatively early in the follow-up period, with 63% occurring within 13 (of 52) weeks in one study and 50% within 8 (of 24) weeks in the other study.[@R8] Several variables were included in risk factor analyses for postdischarge mortality ([table 4](#T4){ref-type="table"}). Increasing age was shown to be a protective factor in all three studies. Parasitaemia was found to be associated with lower PDM compared with other diagnoses in two studies, with the third study showing lower PDM compared with diarrhoea, anaemia and other less common diagnoses. Bacteraemia, severe or very severe pneumonia, severe malnutrition, meningitis and HIV were all associated with a higher probability of postdischarge death.[@R9] In the study by Veirum *et al* that evaluated discharge against medical advice (AMA), those who left AMA were eight times more likely to die after discharge.[@R8] Anthropometric factors (including mid-upper arm circumference (MUAC), weight-for-age, weight-for-height and height-for-age z-scores), hypoxia, respiratory rate, jaundice, hepatomegaly and Blantyre coma scale rating were all associated with a statistically significant increase in the probability of PDM.[@R9] Those who had been hospitalised prior to the index admission were also at increased risk for death, with each additional hospitalisation compounding the risk.[@R9]

###### 

Outcome characteristics

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author ID                                                                                          Intervention/Exposure                                                                         IPM (%)\*                              Follow-up times                                                           Loss to follow-up (%)\*   PD rehospitalised (%)\*    PDM (%)\*     Place of PD death                           PDM statistics†
  -------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------- -------------------------------------- ------------------------------------------------------------------------- ------------------------- -------------------------- ------------- ------------------------------------------- ------------------------------------------------
  All admissions/unspecified infectious admissions                                                                                                                                                                                                                                                                                                                                                                                 

   Veirum *et al* [@R8]                                                                                                                                                                            15                                     Days 1, 14, 30, 91, 182, 365                                              --                                                   8             77% at home\                                63% at 13 w
                                                                                                                                                                                                                                                                                                                                                                                       23% in hospital                             

   Moisi *et al* [@R9]                                                                                                                                                                             --                                     1 year                                                                    --                        17.7                       5.2                                                       

   Wiens *et al* [@R10]                                                                                                                                                                            4.9                                    2, 4, 6 months                                                            1.7                       16.5                       4.9           67% out of hospital\                        50% at 4 w
                                                                                                                                                                                                                                                                                                                                                                                       33% in hospital                             

  Malnutrition                                                                                                                                                                                                                                                                                                                                                                                                                     

   Hennart *et al* [@R14]                                                                                                                                                                          --                                     Every year for 5 years                                                    --                                                   15.9                                                      59% at 52 w

   Kerac *et al* [@R12]                                                                                                                                                                            23.2                                   90 days and 1 year                                                        17.2                      6.62                       24.0                                                      44% at 13 w

   Chisti *et al* [@R13]                                                                                                                                                                           8.6                                    Weekly for 2 weeks then monthly until 6 months                            15.0                                                 8.7           80% at home\                                59% at 4 w\
                                                                                                                                                                                                                                                                                                                                                                                       16% in hospital\                            88% at 9 w
                                                                                                                                                                                                                                                                                                                                                                                       4% on transport                             

   Berkley *et al* [@R15]                                                                            Oral cotrimoxazole prophylaxis                                                                3.4                                    Once per month until 6 months, then once every 2 months until 12 months   5.3                       296 non-fatal admissions   11.1          (32%) in readmission to a study hospital\   
                                                                                                                                                                                                                                                                                                                                                                                       (15%) in other hospitals\                   
                                                                                                                                                                                                                                                                                                                                                                                       (53%) in the community                      

  Placebo                                                                                            5.1                                                                                           320 non-fatal admissions                                                                                                                                                                                                        

   Grenov *et al* [@R32]                                                                             Probiotics                                                                                    11.5                                   At 8--12 weeks                                                            10.4                                                 1.8                                                       

  Placebo                                                                                            8.0                                                                                           7.9                                                                                                              2.4                                                                                                            

  Respiratory infection                                                                                                                                                                                                                                                                                                                                                                                                            

   West *et al* [@R33]                                                                               Hypoxaemia                                                                                    --                                     Mean length of follow-up 41 months                                        36.1                                                 9.6                                                       

  Non-hypoxaemic                                                                                     --                                                                                            Mean length of follow-up 34.1 months   39.3                                                                                                3.7                                                                                  

   Villamor *et al* [@R17]                                                                                                                                                                         3.1                                    Every 2 weeks for a year then every 4 months\                             11.4                                                 10.4                                                      80% by 52 w
                                                                                                                                                                                                                                          Mean duration of follow-up 24.7 months (SD=12.3, median=28.2)                                                                                                                            

   Ashraf *et al* [@R34]                                                                                                                                                                           0                                      Every 2 weeks for 3 months                                                6.4                       6.4                        1.7                                                       

   Reddy *et al* [@R35]                                                                              Standard and intensified diagnostic arms analysed together                                    --                                     2 and 8 weeks post-enrolment                                              --                                                   17.4                                                      50% at 2 w\
                                                                                                                                                                                                                                                                                                                                                                                                                                   'postenrolment deaths'; IP or PD not specified

   Chhibber *et al* [@R16]                                                                                                                                                                         3.9                                    180 days                                                                  --                                                   2.8                                                       55% at 6 w

   Ngari *et al* [@R18]                                                                              Pneumonia                                                                                     5.6                                    Every 4 months until 1 year                                               1.9                                                  3.1           37% in hospital                             44% at 13 w\
                                                                                                                                                                                                                                                                                                                                                                                                                                   74% at 26 w

  No pneumonia                                                                                       2.4                                                                                           0.9                                                                                                              1.3                                                                                                            

   Newberry *et al* [@R36]                                                                           Corticosteroids                                                                               27.8                                   1, 3, 6 months                                                            11.5                                                 19.2                                                      

  Placebo                                                                                            52.4                                                                                          10.0                                                                                                             35.0                                                                                                           

  Diarrhoeal diseases                                                                                                                                                                                                                                                                                                                                                                                                              

   Roy *et al* [@R19]                                                                                                                                                                              --                                     Monthly for 12 months                                                     --                                                   4                                                         52% at 4 w\
                                                                                                                                                                                                                                                                                                                                                                                                                                   70% at 9 w

   Stanton *et al* [@R37]                                                                                                                                                                          1.8                                    At 4--5 months                                                            6.8                                                  2.9                                                       

   Islam *et al* [@R20]                                                                                                                                                                            14.6                                   At 6 and 12 weeks                                                         --                                                   7.5                                                       94% at 6 w

  Anaemia/Malaria                                                                                                                                                                                                                                                                                                                                                                                                                  

   Zucker *et al* [@R24]                                                                             Anaemia                                                                                       13                                     4 and 8 weeks                                                             4.0                                                  18.8                                                      

  No anaemia; figures include the analysed 'no-anaemia cohort' from study plus additional children   9                                                                                             4.0                                                                                                              10.3                                                                                                           

   Biai *et al* [@R21]                                                                               Intervention: improved management and free emergency drugs for malaria, financial incentive   4.6                                    28 days                                                                   3.9                                                  1.8                                                       

  Control                                                                                            9.4                                                                                           4.9                                                                                                              0.9                                                                                                            

   Phiri *et al* [@R25]                                                                              Severe anaemia                                                                                6.4                                    1, 3, 6, 12, 18 months                                                    17.8                      18.1                       11.6                                                      71% at 26 w

  No anaemia                                                                                         0                                                                                             19.6                                   9.3                                                                       2.7                                                  60% at 26 w                                               

   Phiri *et al* [@R23]                                                                              Artemether--lumefantrine                                                                      --                                     1, 3, 6 months                                                            5.0                       21.5                       2.5                                                       50% at 4 w

  Placebo                                                                                            --                                                                                            4.9                                    24.4                                                                      2.3                                                  50% at 9 w                                                

   Olupot-Olupot *et al* [@R26]                                                                      Severe anaemia---higher blood transfusion volume (30 mL/kg)                                   0                                      28 days postadmission                                                     0                                                    1.3                                                       

  Severe anaemia---standard blood transfusion volume (20 mL/kg)                                      7.3                                                                                           0                                                                                                                0                                                                                                              

   Opoka *et al* [@R22]                                                                              Cerebral malaria                                                                              12.6                                   6 months                                                                  2.5                       3.1                        0.6                                                       

  Severe malarial anaemia                                                                            0.4                                                                                           3.6                                    9.4                                                                       2.2                                                                                                            
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Indicates cumulative rates as of the last follow-up time.

†Indicates specified mortality statistics in regard to per cent of total postdischarges by a certain number of weeks, in relation to entire duration of follow-up.

IP, inpatient; IPM, inpatient mortality; PD, postdischarge; PDM, postdischarge mortality; w, week.

###### 

Risk factors for PDM in all admissions/unspecified infectious admission studies

  Article                                                                                                                                                            Risk factor category                                                                            Mortality risk factor on admission                  Estimate type              Estimate (95% CI)         Adjusted
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------- --------------------------------------------------- -------------------------- ------------------------- ----------
  Veirum *et al* [@R8]                                                                                                                                               Age                                                                                             Age at discharge\>5 years (ref: age 1--12 months)   RR                         **0.15 (0.07 to 0.30)**   Yes
  Age at discharge 4 years (ref: age 1--12 months)                                                                                                                   RR                                                                                              **0.23 (0.10 to 0.59)**                             Yes                                                  
  Age at discharge 3 years (ref: age 1--12 months)                                                                                                                   RR                                                                                              **0.14 (0.06 to 0.35)**                             Yes                                                  
  Age at discharge 2 years (ref: age 1--12 months)                                                                                                                   RR                                                                                              **0.52 (0.33 to 0.81)**                             Yes                                                  
  Age at discharge 1 year (ref: age 1--12 months)                                                                                                                    RR                                                                                              0.82 (0.59 to 1.13)                                 Yes                                                  
  Neonatal (ref: age 1--12 months)                                                                                                                                   RR                                                                                              0.69 (0.31 to 1.55)                                 Yes                                                  
  Diagnosis                                                                                                                                                          Diagnosis: other---includes chronic diseases which cannot be treated in Bissau (ref: malaria)   RR                                                  **1.65 (1.08 to 2.55)**    Yes                       
  Anaemia (ref: malaria)                                                                                                                                             RR                                                                                              **1.97 (1.07 to 3.63)**                             Yes                                                  
  Diarrhoea (ref: malaria)                                                                                                                                           RR                                                                                              **1.82 (1.21 to 2.74)**                             Yes                                                  
  Bronchopneumonia (ref: malaria)                                                                                                                                    RR                                                                                              0.98 (0.65 to 1.51)                                 Yes                                                  
  Measles (ref: malaria)                                                                                                                                             RR                                                                                              0.77 (0.36 to 1.64)                                 Yes                                                  
  Hospital stay                                                                                                                                                      Leaving against medical advice                                                                  RR                                                  **8.51 (5.32 to 13.59)**   Yes                       
  Maternal influence                                                                                                                                                 Mother educated (ref: no maternal education)                                                    RR                                                  **0.74 (0.55 to 0.99)**    Yes                       
  Moisi *et al* [@R9]                                                                                                                                                Age                                                                                             Age 1--5 months                                     HR                         1.34 (0.93 to 1.92)       Yes
  Age 6--11 months                                                                                                                                                   HR                                                                                              0.82 (0.57 to 1.18)                                 Yes                                                  
  Age 2--5 years                                                                                                                                                     HR                                                                                              **0.57 (0.36 to 0.90)**                             Yes                                                  
  Sick young infant                                                                                                                                                  HR                                                                                              **2.67 (1.98 to 3.58)**                             Yes                                                  
  Diagnosis                                                                                                                                                          Parasitaemia                                                                                    HR                                                  **0.45 (0.29 to 0.71)**    Yes                       
  Bacteraemia                                                                                                                                                        HR                                                                                              **1.77 (1.15 to 2.74)**                             Yes                                                  
  Mild pneumonia                                                                                                                                                     HR                                                                                              2.30 (1.00 to 5.28)                                 Yes                                                  
  Severe pneumonia                                                                                                                                                   HR                                                                                              **1.37 (1.05 to 1.79)**                             Yes                                                  
  Very severe pneumonia                                                                                                                                              HR                                                                                              **4.09 (2.25 to 7.46)**                             Yes                                                  
  Severe malnutrition                                                                                                                                                HR                                                                                              **4.37 (2.73 to 7.01)**                             Yes                                                  
  Meningitis                                                                                                                                                         HR                                                                                              **2.29 (1.57 to 3.32)**                             Yes                                                  
  Growth parameters                                                                                                                                                  WAZ \< −3                                                                                       HR                                                  **3.42 (2.50 to 4.68)**    Yes                       
  WAZ \< −4                                                                                                                                                          HR                                                                                              **6.53 (4.85 to 8.80)**                             Yes                                                  
  Hospital stay                                                                                                                                                      Hospitalisation\>13 days                                                                        HR                                                  **1.83 (1.33 to 2.52)**    Yes                       
  One prior discharge (occurring within 1 year of index discharge)                                                                                                   HR                                                                                              **2.83 (2.04 to 3.92)**                             Yes                                                  
  Two prior discharges                                                                                                                                               HR                                                                                              **7.06 (4.09 to 12.21)**                            Yes                                                  
  ≥3 prior discharges                                                                                                                                                HR                                                                                              **23.55 (10.70 to 51.84)**                          Yes                                                  
  Symptoms                                                                                                                                                           Hypoxia                                                                                         HR                                                  **2.30 (1.64 to 3.23)**    Yes                       
  Jaundice                                                                                                                                                           HR                                                                                              **1.77 (1.08 to 2.91)**                             Yes                                                  
  Hepatomegaly                                                                                                                                                       HR                                                                                              **2.34 (1.60 to 3.24)**                             Yes                                                  
  Wiens *et al* [@R10] 2015                                                                                                                                          Age                                                                                             Age (months)                                        OR                         **0.97 (0.97 to 0.97)**   No
  Comorbid conditions                                                                                                                                                HIV positive                                                                                    OR                                                  **5.21 (2.55 to 10.65)**   No                        
  Growth parameters                                                                                                                                                  MUAC (mm)                                                                                       OR                                                  **0.97 (0.96 to 0.98)**    No                        
  Weight-for-age z-score                                                                                                                                             OR                                                                                              **0.66 (0.57 to 0.76)**                             No                                                   
  Weight for length/height z-score                                                                                                                                   OR                                                                                              **0.81 (0.72 to 0.91)**                             No                                                   
  Length/height-for-age z-score                                                                                                                                      OR                                                                                              **0.79 (0.70 to 0.89)**                             No                                                   
  Hospital stay                                                                                                                                                      Illness\>7 days prior to admission                                                              OR                                                  **0.50 (0.30 to 0.83)**    No                        
  Time since last hospitalisation (ordered as \<7 days, 7--30 days, 30 days to 1 year, \>1 year and never (analysed as continuous and coded as 1--5, respectively)   OR                                                                                              **0.75 (0.62 to 0.90)**                             No                                                   
  Labs/Assessments                                                                                                                                                   Haemoglobin (g/dL)                                                                              OR                                                  0.95 (0.87 to 1.03)        No                        
  Blantyre coma scale\<5 (ref: 5)                                                                                                                                    OR                                                                                              **2.40 (1.27 to 4.57)**                             No                                                   
  Positive blood smear                                                                                                                                               OR                                                                                              **0.33 (0.16 to 0.68)**                             No                                                   
                                                                                                                                                                     Maternal influence                                                                              Maternal age (years)                                OR                         1.00 (0.97 to 1.04)       No
                                                                                                                                                                     Maternal HIV positive (ref: HIV negative)                                                       OR                                                  1.79 (0.87 to 3.67)        No                        
                                                                                                                                                                     Maternal HIV status unknown (ref: HIV negative)                                                 OR                                                  1.27 (0.64 to 2.52)        No                        
                                                                                                                                                                     Maternal education primary 3--7 (ref: maternal education\<P3)                                   OR                                                  1.18 (0.62 to 2.23)        No                        
                                                                                                                                                                     Maternal education some secondary (ref: maternal education\<P3)                                 OR                                                  0.72 (0.31 to 1.70)        No                        
                                                                                                                                                                     Maternal education postsecondary (ref: maternal education\<P3)                                  OR                                                  1.18 (0.41 to 3.36)        No                        
                                                                                                                                                                     Sex                                                                                             Male                                                OR                         0.90 (0.54 to 1.51)       No
                                                                                                                                                                     Social determinants of health                                                                   Bed net use---sometimes (ref: never)                OR                         1.00 (0.48 to 2.09)       No
                                                                                                                                                                     Bed net use---always (ref: never)                                                               OR                                                  0.85 (0.46 to 1.58)        No                        
                                                                                                                                                                     Siblings death                                                                                  OR                                                  1.54 (0.89 to 2.65)        No                        
                                                                                                                                                                     Number of children in the family                                                                OR                                                  1.02 (0.92 to 1.13)        No                        
                                                                                                                                                                     Boil all drinking water                                                                         OR                                                  0.82 (0.47 to 1.42)        No                        
                                                                                                                                                                     Distance from hospital 30--60 min (ref: distance\<30 min)                                       OR                                                  0.71 (0.31 1.64)           No                        
                                                                                                                                                                     Distance from hospital\>60 min (ref: distance\<30 min)                                          OR                                                  1.30 (0.70 to 2.41)        No                        
                                                                                                                                                                     Vital signs                                                                                     HR for age z-score                                  OR                         **0.86 (0.74 to 0.99)**   No
                                                                                                                                                                     HR (raw)                                                                                        OR                                                  1.00 (0.99 to 1.01)        No                        
                                                                                                                                                                     RR for age z-score                                                                              OR                                                  0.99 (0.92 to 1.06)        No                        
                                                                                                                                                                     RR (raw)                                                                                        OR                                                  1.01 (1.00 to 1.03)        No                        
                                                                                                                                                                     SBP z-score                                                                                     OR                                                  0.94 (0.79 to 1.12)        No                        
                                                                                                                                                                     SBP (raw)                                                                                       OR                                                  0.98 (0.96 to 1.00)        No                        
                                                                                                                                                                     DBP (raw)                                                                                       OR                                                  0.99 (0.97 to 1.01)        No                        
                                                                                                                                                                     Temperature (transformed)                                                                       OR                                                  1.02 (0.90 to 1.16)        No                        
                                                                                                                                                                     Temperature (raw)                                                                               OR                                                  **0.76 (0.62 to 0.93)**    No                        
                                                                                                                                                                     SpO~2~ (raw)                                                                                    OR                                                  **0.94 (0.92 to 0.96)**    No                        
                                                                                                                                                                     SpO~2~ (transformed)                                                                            OR                                                  **1.04 (1.02 to 1.05)**    No                        

Bolded values are statistically significant.

DBP, diastolic blood pressure; PDM, postdischarge mortality; RR, relative risk; SBP, systolic blood pressure; WAZ, weight for age z-score.

Malnutrition {#s3c}
------------

Five studies focusing on a malnourished population were identified. These studies were conducted in the Democratic Republic of the Congo, Malawi, Bangladesh, Kenya and Uganda between 1970 and 2015 and and enrolled between 171 and 1778 children ([table 2](#T2){ref-type="table"}). The period of follow-up varied widely in this subpopulation, ranging from 8 weeks to 5 years ([table 3](#T3){ref-type="table"}). Postdischarge mortality rates were observed to be between 1.8% and 24%. Where hospital mortality rates were measured (n=2), mortality following discharge was comparable to that observed during hospital admission, with one study reporting an inpatient mortality rate of 23.2% (24% after discharge), and a second study of 8.6% (8.7% after discharge).[@R12] Three of four studies specified the timing of deaths during the follow-up period with all finding that the majority of deaths following discharge occurred early during the follow-up period (relative to total follow-up). In one study, 59% of those who died after discharge did so within 52 weeks (of 5 years),[@R14] another found that 44% died within 13 (of 52) weeks,[@R12] and the third study observed 88% dying within 9 (of 26) weeks of discharge.[@R13] A study conducted in Bangladesh reporting the location of postdischarge death found that 80% of deaths occurred at home, while another conducted in Kenya found 53% occurring in the community.[@R13] Anthropometric parameters including MUAC, weight-for-age and weight-for-height z-scores were among the highly significant predictors for death postdischarge ([table 5](#T5){ref-type="table"}).[@R12] Age \<12 months was associated with mortality in one study, but was found not to be significant in another, although wide CIs could not rule out an important effect.[@R12] Highly significant associations variables included positive HIV status (HR 4.03; 95% CI 3.08 to 5.25), unknown HIV status (HR 16.90; 95% CI 12.10 to 23.70) and discharge AMA (HR 4.68; 95% CI 2.01 to 10.85).

###### 

Risk factors for PDM in malnutrition studies

  Article                                                    Risk factor category                                       Mortality risk factor on admission   Estimate type             Estimate (95% CI)         Adjusted
  ---------------------------------------------------------- ---------------------------------------------------------- ------------------------------------ ------------------------- ------------------------- ----------
  Hennart *et al* [@R14]                                     No data                                                                                                                                             
  Kerac *et al* [@R12]                                       Age                                                        Age\>60 m (ref: age 48--60 m)        HR                        1.22 (0.63 to 2.36)       Yes
  Age 36--48 m (ref: age 48--60 m)                           HR                                                         1.66 (0.84 to 3.29)                  Yes                                                 
  Age 24--36 m (ref: age 48--60 m)                           HR                                                         1.38 (0.76 to 2.49)                  Yes                                                 
  Age 12--24 m (ref: age 48--60 m)                           HR                                                         1.57 (0.89 to 2.78)                  Yes                                                 
  Age\<12 m (ref: age 48--60 m)                              HR                                                         **2.49 (1.38 to 4.51)**              Yes                                                 
  Comorbid conditions                                        HIV positive (ref: HIV negative)                           HR                                   **4.03 (3.08 to 5.25)**   Yes                       
  HIV unknown status (ref: HIV negative)                     HR                                                         **16.90 (12.10 to 23.70)**           Yes                                                 
  Growth parameters                                          Oedema                                                     HR                                   **0.58 (0.47 to 0.72)**   Yes                       
  MUAC per cm unit increase                                  HR                                                         **0.80 (0.74 to 0.86)**              Yes                                                 
  Weight-for-height: per 1 unit z-score increase             HR                                                         **0.75 (0.68 to 0.83)**              Yes                                                 
  Weight-for-age: per 1 unit z-score increase                HR                                                         **0.73 (0.66 to 0.81)**              Yes                                                 
  Height-for-age: per 1 unit z-score increase                HR                                                         **0.92 (0.86 to 0.99)**              Yes                                                 
  Sex                                                        Male                                                       HR                                   0.89 (0.73 to 1.08)       Yes                       
  Chisti *et al* [@R13]                                      Age                                                        Age\<12 m                            OR                        2.05 (0.90 to 4.90)       No
  Comorbid conditions                                        Confirmed TB                                               OR                                   1.74 (0.40 to 6.90)       No                        
  Clinical TB---not confirmed                                OR                                                         0.15 (0.01 to 1.10)                  No                                                  
  History of previous pneumonia prior to present episode     OR                                                         **3.4 (1.1 to 10.2)**                No                                                  
  Growth parameters                                          Severe wasting\* (z-score \<−4 weight-for-height/length)   OR                                   **3.4 (1.5 to 7.8)**      No                        
  Severe underweight\* (z-score \<−5 weight-for-age)         OR                                                         **3.05 (1.4 to 6.8)**                No                                                  
  Severe wasting (z-score \<−4 weight-for-height/length)     OR                                                         **2.74 (1.2 to 6.2)**                No                                                  
  Severe underweight (z-score \<−5 weight-for-age)           OR                                                         **2.82 (1.2 to 6.7)**                No                                                  
  Nutritional oedema                                         OR                                                         2.34 (0.5 to 9.6)                    No                                                  
  Hospital stay                                              Left against medical advice\*                              OR                                   **4.16 (1.5 to 11.3)**    No                        
  Sex                                                        Male                                                       OR                                   0.68 (0.3 to 1.5)         No                        
  Social determinants of health                              Live outside Dhaka district                                OR                                   1.69 (0.7 to 4)           No                        
  Poor socioeconomic condition−income\<US\$125 per month     OR                                                         0.73 (0.3 to 2)                      No                                                  
  Symptoms                                                   Lower chest wall in-drawing                                OR                                   0.86 (0.4 to 1.9)         No                        
  Hypoxaemia (arterial oxygen saturation\<90% in room air)   OR                                                         1.23 (0.3 to 4.7)                    No                                                  
  Berkley *et al* [@R15]                                     Intervention                                               Cotrimoxazole vs placebo             HR                        **0.90 (0.71 to 1.16)**   No
  Grenov *et al* [@R32]                                                                                                 No data                                                                                  

Bolded values are statistically significant.

\*Risk factor for mortality assessed on discharge.

m, month; PDM, postdischarge mortality; TB, tuberculosis.

Respiratory infection {#s3d}
---------------------

Seven studies examining respiratory infections were identified. These included children with a variety of inclusion criteria, including pneumonia, acute lower respiratory tract infection and tuberculosis. Studies were conducted between 1992 and 2014 in the Gambia, Tanzania, Bangladesh, Malawi and Kenya ([table 2](#T2){ref-type="table"}). Mortality rates postdischarge ranged widely, from 1.3% to 35% across the studies. These rates, however, remained consistently comparable to inpatient mortality when both were measured ([table 3](#T3){ref-type="table"}). As with other populations, mortality rates generally occurred early during follow-up. A large prospective cohort study by Ngari *et al* including children aged 1--59 months with severe pneumonia found that 74% of postdischarge deaths occurred by 26 (of 52) weeks with 63% occurring outside of the hospital. Chhibber *et al* [@R16] conducted a study of 3952 children admitted primarily with pneumonia in rural Gambia, and sought to identify specific comorbidities and physiologic factors predictive of mortality after discharge. This study found that physiologic factors, including neck stiffness, oxygen saturation, temperature and haemoglobin concentration were associated with postdischarge mortality. Malnutrition-related variables (clinical malnutrition and low MUAC) were the strongest predictors of postdischarge mortality, producing HRs ranging from 18.4 to 43.7 ([table 6](#T6){ref-type="table"}). Although individual studies differed in regard to whether risk factors were measured continuously, categorically or dichotomously, it is clear that the directionality of certain risk factors such as low haemoglobin and low MUAC continue to be associated with higher PDM in children admitted for respiratory illness.[@R16] When examining the timing of mortality, most cases occurred relatively early during follow-up. One study found that 80% had occurred by 12 months (mean duration of follow-up 24.7 months),[@R17] another study had 55% by 6 (of 26) weeks[@R16] and yet another reported 74% by 26 (of 52) weeks.[@R18] Low MUAC, stunting, HIV-positive status, jaundice, low haemoglobin, under 24 months of age and availability of water were significant predictors of postdischarge mortality among children with respiratory illness.[@R17]

###### 

Risk factors for PDM in respiratory infection studies

  Article                                                                              Risk factor category                                                                                                           Mortality risk factor on admission                                                  Estimate type              Estimate (95% CI)          Adjusted
  ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------- -------------------------- -------------------------- ----------
  West *et al* [@R33]                                                                  No data                                                                                                                                                                                                                                                                  
  Villamor *et al* [@R17]                                                              Age                                                                                                                            Age 6--11 m (ref: \>24 m)                                                           HR                         **3.70 (1.72 to 7.95)**    Yes
  Age 12--23 m (ref: \>24 m)                                                           HR                                                                                                                             **3.14 (1.44 to 6.88)**                                                             Yes                                                   
  Comorbid conditions                                                                  HIV positive                                                                                                                   HR                                                                                  **3.92 (2.34 to 6.55)**    Yes                        
  Diagnosis                                                                            Severe pneumonia on admission                                                                                                  HR                                                                                  **2.47 (1.59 to 3.85)**    Yes                        
  Growth parameters                                                                    Stunted at baseline (2 z-scores (NCHS/WHO reference) in height-for-age Wasted children were 2 z-scores in weight-for-height)   HR                                                                                  **2.12 (1.31 to 3.42)**    Yes                        
  Low MUAC at baseline (25th percentile of the population age-specific distribution)   HR                                                                                                                             **1.88 (1.16 to 3.03)**                                                             Yes                                                   
                                                                                       Labs/Assessments                                                                                                               Haemoglobin (Hgb) concentration\<7.00 (g/dL) (ref: Hgb concentration\>10 g/dL)      HR                         **2.55 (1.13 to 5.77)**    Yes
                                                                                       Hgb concentration 7.01--8.50 g/dL (ref: Hgb concentration\>10 g/dL)                                                            HR                                                                                  **2.81 (1.24 to 6.37)**    Yes                        
                                                                                       Hgb concentration 8.51--10.00 g/dL (ref: Hgb concentration\>10 g/dL)                                                           HR                                                                                  1.76 (0.75 to 4.10)        Yes                        
                                                                                       Maternal influence                                                                                                             Maternal education---elementary (ref: no maternal education)                        HR                         0.84 (0.48 to 1.49)        Yes
                                                                                       Maternal education---secondary or higher (ref: no maternal education)                                                          HR                                                                                  0.27 (0.06 to 1.17)        Yes                        
                                                                                       Mother works outside home                                                                                                      HR                                                                                  0.61 (0.36 to 1.03)        Yes                        
                                                                                       Mother not living with partner                                                                                                 HR                                                                                  1.60 (1.00 to 2.57)        Yes                        
                                                                                       Sex                                                                                                                            Male                                                                                HR                         0.98 (0.65 to 1.48)        Yes
                                                                                       Social determinants of health                                                                                                  Water tap in compound (ref: water tap in house)                                     HR                         1.40 (0.60 to 3.29)        Yes
                                                                                       Water tap outside compound (ref: water tap in house)                                                                           HR                                                                                  **2.27 (1.02 to 5.03)**    Yes                        
                                                                                       Public well (ref: water tap in house)                                                                                          HR                                                                                  **2.92 (1.03 to 8.30)**    Yes                        
  Ashraf *et al* [@R34]                                                                No data                                                                                                                                                                                                                                                                  
  Reddy *et al* [@R35]                                                                 Intervention                                                                                                                   Not receiving anti-TB medication (predictor of death within 2 weeks of admission)   OR                         **0.25 (0.03 to 2.00)**    No
  Not receiving anti-TB medication (predictor of death within 8 weeks of admission)    OR                                                                                                                             **0.20 (0.04 to 0.96)**                                                             No                                                    
  Chhibber *et al* [@R16]                                                              Age                                                                                                                            Age (m)                                                                             HR                         1.00 (0.98 to 1.03)        Yes
  Comorbid conditions                                                                  Sepsis with clinically severe malnutrition (CSM); (ref: pneumonia without CSM)                                                 HR                                                                                  **18.4 (11.3 to 30.0)**    Yes                        
  Meningitis with CSM (ref: pneumonia without CSM)                                     HR                                                                                                                             **13.7 (4.2 to 44.7)**                                                              Yes                                                   
  Pneumonia with CSM (ref: pneumonia without CSM)                                      HR                                                                                                                             **8.1 (4.4 to 14.8)**                                                               Yes                                                   
  Meningitis without CSM (ref: pneumonia without CSM)                                  HR                                                                                                                             **2.6 (1.2 to 5.5)**                                                                Yes                                                   
  Sepsis without CSM (ref: pneumonia without CSM)                                      HR                                                                                                                             **2.2 (1.1 to 4.3)**                                                                Yes                                                   
  Growth parameters                                                                    MUAC 11.5--13.0 cm (ref: MUAC\>13 cm)                                                                                          HR                                                                                  **7.19 (3.04 to 17.01)**   Yes                        
  MUAC 10.5--11.4 cm (ref: MUAC\>13 cm)                                                HR                                                                                                                             **24.2 (9.4 to 61.9)**                                                              Yes                                                   
  MUAC\<10.5 cm (ref: MUAC\>13 cm)                                                     HR                                                                                                                             **43.7 (17.7 to 108.0)**                                                            Yes                                                   
                                                                                       Hospital stay                                                                                                                  Non-medical discharge                                                               HR                         **4.68 (2.01 to 10.85)**   Yes
                                                                                       Labs/Assessments                                                                                                               Hgb concentration (g/dL)                                                            HR                         **0.82 (0.73 to 0.91)**    Yes
                                                                                       Social determinants of health                                                                                                  Dry season                                                                          HR                         **1.96 (1.16 to 3.32)**    Yes
                                                                                       Sym                                                                                                                            Neck stiffness                                                                      HR                         **10.4 (3.1 to 34.8)**     Yes
                                                                                       Vital signs                                                                                                                    Axillary temperature (°C)                                                           HR                         **0.71 (0.58 to 0.87)**    Yes
                                                                                       SpO~2~ (%)                                                                                                                     HR                                                                                  **0.96 (0.93 to 0.99)**    Yes                        
  Ngari *et al* [@R18]                                                                 Age                                                                                                                            Age 12--23 m (ref: age\>24 m)                                                       HR                         1.0 (0.1 to 9.6)           Yes
  Age 6--11 m (ref: age\>24 m)                                                         HR                                                                                                                             5.8 (0.8 to 40.5)                                                                   Yes                                                   
  Age\<6 m (ref: age\>24 m)                                                            HR                                                                                                                             4.8 (0.7 to 34.1)                                                                   Yes                                                   
  Comorbid conditions                                                                  Reported preterm/low birth weight                                                                                              HR                                                                                  0.7 (0.2 to 2.8)           Yes                        
  HIV antibody test positive                                                           HR                                                                                                                             **6.5 (2.3 to 18.4)**                                                               Yes                                                   
  HIV test not performed                                                               HR                                                                                                                             0.4 (0.1 to 3.6)                                                                    Yes                                                   
  RSV test positive                                                                    HR                                                                                                                             0.3 (0.1 to 1.2)                                                                    Yes                                                   
  RSV test not performed                                                               HR                                                                                                                             **2.7 (1.2 to 6.3)**                                                                Yes                                                   
  Malaria slide positive                                                               HR                                                                                                                             0.5 (0.1 to 5.2)                                                                    Yes                                                   
  Bacteraemia                                                                          HR                                                                                                                             0.8 (0.1 to 5.2)                                                                    Yes                                                   
  Growth parameters                                                                    MUAC per cm                                                                                                                    HR                                                                                  **0.6 (0.5 to 0.8)**       Yes                        
  Hospital stay                                                                        Duration of hospitalisation (per day)                                                                                          HR                                                                                  1.1 (1.0 to 1.2)           Yes                        
                                                                                       Hospital stay                                                                                                                  Year of admission 2008 (ref: 2007 admission year)                                   HR                         0.9 (0.3 to 3.1)           Yes
                                                                                       Year of admission 2009 (ref: 2007 admission year)                                                                              HR                                                                                  0.5 (0.1 to 2.1)           Yes                        
                                                                                       Year of admission 2010 (ref: 2007 admission year)                                                                              HR                                                                                  0.7 (0.2 to 2.5)           Yes                        
                                                                                       Year of admission 2011 (ref: 2007 admission year)                                                                              HR                                                                                  1.7 (0.5 to 5.3)           Yes                        
                                                                                       Year of admission 2012 (ref: 2007 admission year)                                                                              HR                                                                                  1.8 (0.2 to 15.7)          Yes                        
                                                                                       Labs/Assessments                                                                                                               Severe anaemia (Hgb\<5 g/dL)                                                        HR                         0.8 (0.1 to 7.5)           Yes
                                                                                       Sex                                                                                                                            Female                                                                              HR                         0.5 (0.3 to 1.1)           Yes
                                                                                       Social determinants of health                                                                                                  Residence distance from hospital (per km)                                           HR                         1.0 (0.9 to 1.1)           Yes
                                                                                       Symptoms                                                                                                                       Capillary refill\>2 s                                                               HR                         2.4 (0.5 to 12.1)          Yes
                                                                                       Impaired consciousness                                                                                                         HR                                                                                  1.1 (0.2 to 7.8)           Yes                        
                                                                                       Wheezing                                                                                                                       HR                                                                                  0.5 (0.1 to 2.4)           Yes                        
                                                                                       Cough for\>14 days                                                                                                             HR                                                                                  0.2 (0.1 to 5.5)           Yes                        
                                                                                       Jaundice                                                                                                                       HR                                                                                  **12.5 (1.1 to 13.7)**     Yes                        
                                                                                       Vital signs                                                                                                                    Hypoxia (SaO~2~\<90%)                                                               HR                         1.9 (0.7 to 5.4)           Yes
                                                                                       Axillary temperature\<36°C (ref: axillary temperature 36°C--39°C)                                                              HR                                                                                  0.3 (0.1 to 2.8)           Yes                        
                                                                                       Axillary temperature\>39°C (ref: axillary temperature 36°C--39°C)                                                              HR                                                                                  1.1 (0.4 to 3.0)           Yes                        
  Newberry *et al* [@R36]                                                              Intervention                                                                                                                   Prednisone (ref: placebo)                                                           RR                         **0.63 (0.41 to 0.95)**    

Bolded values are statistically significant.

m, month; NCHS, National Center for Health Statistics; PDM, postdischarge mortality; RR, relative risk; TB, tuberculosis.

Diarrhoeal diseases {#s3e}
-------------------

Three studies of paediatric patients with diarrhoea conducted between 1979 and 1992 were included, all three of which were conducted in Bangladesh ([table 2](#T2){ref-type="table"}). Included studies enrolled children aged 1--72 months and found postdischarge death rates of between 2% and 8%, all being generally comparable to in-hospital rates ([table 3](#T3){ref-type="table"}). Deaths occurred within the first few weeks after discharge, with one study reporting 52% by 4 (of 52) weeks,[@R19] and a second reporting 94% of deaths occurring by 6 (of 12) weeks postdischarge.[@R20] Significant risk factors for death after discharge identified in this set of studies included young age (\<6 months), not having been breast fed, malnutrition (based on Height for age z-score (HAZ) and WAZ scores), low levels of maternal education and immunisation status of the child ([table 7](#T7){ref-type="table"}).

###### 

Risk factors for PDM in diarrhoea studies

  Article                         Risk factor category                         Mortality risk factor on admission   Estimate type             Estimate (95% CI)         Adjusted
  ------------------------------- -------------------------------------------- ------------------------------------ ------------------------- ------------------------- ----------
  Roy *et al* [@R19]              No data                                                                                                                               
  Stanton *et al* [@R37]          No data                                                                                                                               
  Islam *et al* [@R20]            Age                                          Age\<6 months                        RR                        **4.57 (2.90 to 7.18)**   Yes
  Growth parameters               Weight-for-age median\<60%                   RR                                   1.04 (0.57 to 1.89)       Yes                       
  Length-for-age median\<85%      RR                                           **2.97 (1.43 to 6.16)**              Yes                                                 
  Maternal influence              Mother's education (no school vs \>1 year)   RR                                   **2.12 (1.37 to 3.28)**   Yes                       
  No breast feeding               RR                                           **2.35 (1.44 to 3.84)**              Yes                                                 
  Sex                             Female                                       RR                                   **1.73 (1.14 to 2.65)**   Yes                       
  Social determinants of health   Immunisation not up-to-date                  RR                                   **1.36 (1.25 to 1.48)**   Yes                       

Bolded values are statistically significant.

PDM, postdischarge mortality; RR, relative risk.

Anaemia and/or malaria {#s3f}
----------------------

Six studies were conducted between 1991 and 2014 in Kenya, Guinea-Bissau, Malawi and Uganda in children with anaemia and/or malaria ([table 2](#T2){ref-type="table"}). Studies were heterogeneous in their specified populations, including children with various illness severity, with mortality postdischarge ranging from 0.9% to 18.8%, and with follow-up periods ranging from 1 to 18 months ([table 3](#T3){ref-type="table"}). In the only study looking specifically at acute malaria, postdischarge mortality (1.8% intervention; 0.9%% control) was lower than inpatient mortality (4.6% intervention; 9.4% control) over a follow-up period of 28 days.[@R21] Another study that followed children with cerebral malaria or severe malarial anaemia for 6 months following discharge reported that although children with cerebral malaria experienced higher inpatient mortality (13% compared with 0.4%), those with severe malarial anaemia had a higher rate of death after discharge (2.2% compared with 0.6%).[@R22] A large study (n=1414) by Phiri *et al* examining severe malarial anaemia found high rates of postdischarge readmission (approximately 22%), with rates of death at approximately 2.4%.[@R23] Children with anaemia experienced higher rates of inpatient (13% anaemia; 9% no anaemia) and postdischarge mortality (18.8% anaemia; 10.3% no anaemia).[@R24] In both cohorts, death after discharge was greater than death in-hospital. Rates of readmission to hospital within 18 months were quantified in one study (18.4% severe anaemia; 9% no anaemia) and postdischarge mortality rates (11.6% anaemia; 2.7% no anaemia) exceed those of inpatient mortality rates (6.4% anaemia; 0% no anaemia).[@R25] Although this study had approximately 18% loss to follow-up, 71% of anaemic and 60% of non-anaemic total postdischarge deaths had occurred by 26 (of 78) weeks.[@R25] An RCT conducted in Uganda studied the effect of transfusion volume (30 mL/kg vs the standard 20 mL/kg) in severely anaemic children, which showed reduced inpatient mortality rates but no difference for deaths after discharge ([table 8](#T8){ref-type="table"}).[@R26] Rates of death were consistently higher after discharge than in hospital in paediatric patients presenting with malaria and/or anaemia. Of risk factors identified throughout these studies, severe anaemia was found to be highly significant for postdischarge death[@R24] and readmission to the hospital.[@R22] HIV status profoundly influenced mortality, with a HR of 10.49 (95% CI 4.05 to 27.20) for death postdischarge in children who tested positive.[@R25]

###### 

Risk factors for PDM in anaemia/malaria studies

  Article                                  Risk factor category                        Mortality risk factor on admission                                    Estimate type               Estimate (95% CI)            Adjusted
  ---------------------------------------- ------------------------------------------- --------------------------------------------------------------------- --------------------------- ---------------------------- -------------
  Biai *et al* [@R21]                      No data                                                                                                                                                                    
  Phiri *et al* [@R25]                     Age                                         Age (months)                                                          HR                          **0.92 (0.87 to 0.97)**      Yes
  Comorbid conditions                      HIV positive                                HR                                                                    **10.49 (4.05 to 27.20)**   Yes                          
  Bacteraemia                              HR                                          2.17 (0.84 to 5.64)                                                   Yes                                                      
  Diagnosis                                Malaria (any parasite/mL blood)             HR                                                                    1.25 (0.67 to 2.34)         No                           
  Growth parameters                        Wasting (\<−2 z-score weight-for-height)    HR                                                                    0.74 (0.31 to 1.80)         No                           
  Stunting (\<−2 z-score height-for-age)   HR                                          0.61 (0.30 to 1.22)                                                   No                                                       
  Labs/Assessments                         Iron deficiency (\>5.6 sTfR/log ferritin)   HR                                                                    0.91 (0.41 to 2.03)         No                           
  Maternal influence                       Mother education (some)                     HR                                                                    1.63 (0.72 to 3.70)         No                           
  Sex                                      Male                                        HR                                                                    1.54 (0.68 to 3.52)         Yes                          
  Social determinants of health            Rural residency                             HR                                                                    1.63 (0.63 to 4.20)         Yes                          
  Parents unemployed                       HR                                          **4.15 (1.61 to 10.74)**                                              Yes                                                      
  Symptoms                                 Splenomegaly                                HR                                                                    **0.36 (0.16 to 0.80)**     Yes                          
  Phiri *et al* [@R23]                     No data                                                                                                                                                                    
  Zucker *et al* [@R24]                    Intervention                                PS, quinine, TS treatment x5d (ref: chloroquine or no antimalarial)   RR                          **0.33 (0.19 to 0.65)**      Unspecified
  Labs/Assessments                         Severe anaemia (Hgb\<5 g/dL)                RR                                                                    **1.52 (1.22 to 1.90)**     Unspecified                  
  Olupot-Olupot *et al* [@R26]             Intervention                                30 mL/kg transfusion vs 20 mL/kg transfusion                          RR                          0.18 (0.02 to 1.42)          Unspecified
  Opoka *et al* [@R22]                     Diagnosis                                   Severe malarial anaemia\*                                             HR                          **16.26 (2.03 to 130.34)**   Yes
  Cerebral malaria\*                       HR                                          4.45 (0.51 to 38.55)                                                  Yes                                                      

\*Risk factor for readmission.

Hgb, haemoglobin; PDM, postdischarge mortality; RR, relative risk.

Discussion {#s4}
==========

Twenty-four studies examining postdischarge mortality in paediatric populations in developing countries were included in this systematic review, together substantiating the significant and unaddressed challenge continuing to plague children around the world. Significant heterogeneity in study characteristics was noted, within inclusion criteria, study design, length of follow-up, interventions (if any), risk factors and risk factor definitions. Studies were conducted primarily in African countries, and examined a variety of populations, including all admissions, infectious disease admissions, malnutrition, respiratory infections, diarrhoea, malaria and anaemia. Studies examining anaemia and/or malaria had the lowest PDM rates, while those of malnutrition and respiratory infections had the highest. Results from the studies identified through the updated search generally reflected the results from the earlier systematic review; rates of postdischarge mortality continued to be high and comparable to (sometimes exceeding) in-hospital mortality, with most postdischarge deaths occurring at home.[@R5] With so many deaths occurring after discharge, it is critical that effective interventions be developed and evaluated as a means to addressing this neglected cause of childhood deaths. Furthermore, no analysis of cause for death postdischarge was identified within any of the reviewed studies, highlighting this as an important area for further research.

When reported, over two-thirds of postdischarge deaths were noted to occur outside of the hospital, generally at home. In order to develop interventions to reduce the burden of PDM, an understanding of circumstances and barriers to care following discharge is of utmost importance. In a recent qualitative study, mothers of children who died postdischarge identified barriers to seeking care prior to their child's death; barriers included lack of access to health facilities and services, poor health-seeking behaviour, finances, transportation and a lack of recognition of symptoms and perceptions of recovery in children recently discharged even in the midst of persisting illness.[@R27] Additional factors that contribute to poor socioeconomic conditions may relate to deaths after discharge, as they further disadvantage children and families. Socioeconomically disadvantaged children continue to be served by health sectors that are poorly resourced and lack the resilience to be able to deal with large numbers of patients seen every day. Follow-up care after initial hospitalisation is an important and yet largely ignored aspect of comprehensive healthcare in both developing countries.[@R2] With so few patients returning to the healthcare system after discharge, identifying and understanding the barriers and targeted interventions required to enhance outcomes must be initiated during the original hospitalisation.

Risk factors consistently identified across all types of infectious admissions as highly associated with postdischarge mortality included HIV status, young age, pneumonia, malnutrition, anthropometric factors, hypoxia, anaemia, leaving the hospital against medical advice and previous hospitalisations. An important observation, therefore, is that regardless of the underlying infectious aetiology, certain risk factors consistently identify vulnerability. These observations suggest that vertical, disease-based, approaches to addressing postdischarge mortality are likely to be ineffective in comparison to simple, broadly applicable interventions. Specific illness (ie, pneumonia, diarrhoea, malaria) are often both difficult to differentiate clinically and often co-exist, especially in children in low-resource settings.[@R28] Sepsis, therefore, as the final common pathway for the majority of infectious disease-related deaths, may be a helpful framework within which to explore paediatric postdischarge mortality and to develop interventions. Instead of focusing on a specific body system or infectious agent, pragmatic interventions towards time-sensitive treatment can be focused towards sepsis as the overarching syndrome, increasing the potential for impactful results.[@R28] The Integrated Management of Childhood Illness (IMCI) pocketbook by the WHO uses a similar approach through their identification of danger signs and treatments as opposed to individual diseases. Addressing sepsis through clinical management is an important component in the reduction of preventable childhood death, requiring sustained efforts by the global community including healthcare providers, patients, pharmaceutical companies and policy makers if large-scale change is to occur.[@R29]

While knowledge of risk factors alone has only moderate utility in the identification of vulnerable children, the development of robust prediction models can provide a more reliable means of risk evaluation. In resource-limited environments, the use of prediction modelling is appealing, especially in relation to interventions aimed at improving postdischarge outcomes. A recent proof-of-concept study found that a simple discharge intervention including education and routine postdischarge follow-up could substantially improve postdischarge health seeking and health outcomes.[@R30] Such approaches, if focused primarily on the most vulnerable children, can ensure that limited resources are most effectively used and have the highest possible level of cost-effectiveness.

This systematic review is subject to several important limitations. First, it is possible that some relevant articles may not have been identified through the systematic search. Although the search was comprehensive, including both Medline and EMBASE, no MeSH/Emtree terms currently exist for postdischarge mortality and even so, many studies measure postdischarge mortality as a secondary end point. A further limitation of this review is that the studies included were predominantly based in African countries. Therefore, these results may not be as applicable to countries outside of this setting. This highlights the continued need for ongoing research in resource-poor settings both within and outside of Africa. Significant heterogeneity in duration of follow-up, as well as when postdischarge mortality was assessed, was noted between the studies, potentially leading to a decreased ability to compare mortality rates. Many studies included in this review had high losses to follow-up (ranging between 0% and 39.3%), and very few were conducted prospectively with the stated intent of exploring postdischarge mortality. Studies with significant attrition due to follow-up likely underestimate the true rate of postdischarge mortality as these losses undoubtedly represent a more vulnerable population. While one study focused on barriers to care following discharge among those children who died in the community, one important remaining gap is that studies did not evaluate the causes of postdischarge mortality, which is difficult to measure given that most deaths occur in the community.[@R10] The ongoing, multicountry, Childhood Acute Illness and Nutrition (CHAIN) network, is attempting to understand the specific reasons for deaths postdischarge among malnourished children.[@R31] It is through contributions such as this that further interventions can be developed and implemented that target the specific and causal factors affecting paediatric mortality rates in developing countries.

Conclusions {#s5}
===========

In conclusion, the studies identified emphasise the significant burden of postdischarge mortality in countries where overextended and resource-limited health systems serve millions of socioeconomically disadvantaged children. The scale of this burden continues to be under-recognised, in part due to the inability of health systems to observe patient outcomes after discharge. Addressing these issues with specific regard to the identification of vulnerable children, and the development of effective postdischarge interventions, will be an essential component towards the achievement of the child mortality targets of the SDGs.
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